Log In
BCIQ
Print this Print this
 

FLAG-003

  Manage Alerts
Collapse Summary General Information
Company Flag Therapeutics Inc.
DescriptionSmall molecule receptor tyrosine kinase (RTK) inhibitor
Molecular Target Receptor tyrosine kinase (RTK)
Mechanism of ActionTubulin inhibitor; Receptor tyrosine kinase (RTK) modulator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBrain cancer
Indication DetailsTreat glioma
Regulatory Designation U.S. - Orphan Drug (Treat glioma);
EU - Orphan Drug (Treat glioma)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today